“Players in cardiometabolic therapeutic areas used to beg for attention at JP Morgan conferences but now they can barely fend people off” – Ali Pashazadeh, Treehill Partners CEO, is quoted in this Mergermarket article by John Smith:
https://mergermarket.ionanalytics.com/content/1004210040?source=news
(Subscription required to access the full article)
While drugs and devices can provide small stepwise benefits, the most transformative approach to cardiovascular disease would be a greater focus on prevention with a growing societal focus on promoting healthy lifestyles.